Filter
264
Filtered Results: 264
Text search:
Ferreia,
R.
Featured
Recommendations
31
New Publications
28
Language
Document type
No document type
83
Studies & Reports
77
Guidelines
55
Manuals
23
Strategic & Response Plan
11
Training Material
6
Resource Platforms
4
Fact sheets
3
Situation Updates
2
Countries / Regions
Brazil
38
Latin America and the Carribbean
16
Paraguay
10
Global
9
Mozambique
7
Western and Central Europe
6
Russia
6
Colombia
5
Ukraine
5
Kenya
4
South Africa
4
Eastern Europe
4
Germany
3
Tajikistan
2
Kazakhstan
2
Kyrgyzstan
2
Africa
2
Venezuela
2
Eastern Europe and Central Asia
2
France
2
Portugal
2
Argentina
2
Vietnam
2
Mexico
1
Turkey
1
China
1
Haiti
1
Tanzania
1
West and Central Africa
1
Middle East and North Africa
1
North America
1
Uruguay
1
United Kingdom
1
Spain
1
Southern Africa
1
Moldova
1
Ethiopia
1
Angola
1
India
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
94
Public Health
20
Clinical Guidelines
17
Women & Child Health
6
Key Resources
6
Capacity Building
5
Pharmacy & Technologies
1
Toolboxes
COVID-19
64
Mental Health
31
NTDs
28
TB
22
NCDs
19
HIV
14
Rapid Response
10
Planetary Health
10
Zika
8
Caregiver
7
AMR
7
Disability
6
Natural Hazards
4
Conflict
4
Pharmacy
3
Global Health Education
3
Refugee
2
Ebola & Marburg
2
Specific Hazards
1
Health Financing Toolbox
1
In this review, the editors will investigate the impact of eight WASH interventions in preventing (reducing the risk of) and controlling outbreaks in LMIC, with particular focus on three diseases of current concern to the response community – cholera, Ebola, and Hepatitis E. Additionally, we will ...
Print version ISSN 1809-9823On-line version ISSN 1981-2256
Rev. bras. geriatr. gerontol. vol.19 no.2 Rio de Janeiro Mar./Apr. 2016
http://dx.doi.org/10.1590/1809-98232016019.150040
The 2019 edition treating data for 2018 marks sustained international efforts dedicated to reporting on, analysing and understanding the year-to-year variations and long-term trends of a changing climate.
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The Lancet Regional Health Americas Volume 37100832 September 2024
A manual for programme managers.
БОРЬБА С ТУБЕРКУЛЕЗОМ В ТЮРЬМАХ
Руководство для руководителей программ
Rapport sur les populations clés.
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infec...
Key population brief.
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
English Analysis on Brazil about Health, Protection and Human Rights and Epidemic; published on 26 May 2021 by SSHAP
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
This revision covers the main non-communicable diseases in Mozambique as well as the National Strategic Plan's aim to create a positive environment to minimize or eliminate the exposure to risk factors and guarantee access to care.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The ...
